Aptevo Therapeutics Inc.·4

Jun 3, 4:31 PM ET

Kwon SoYoung 4

4 · Aptevo Therapeutics Inc. · Filed Jun 3, 2024

Insider Transaction Report

Form 4
Period: 2024-05-31
Kwon SoYoung
SVP, GC, BD & Corp Affairs
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2024-05-31420 total
    Common Stock (42 underlying)
  • Exercise/Conversion

    Common Stock

    2024-05-31+42588 total
Footnotes (3)
  • [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
  • [F2]On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
  • [F3]On June 1, 2021, the reporting person was granted 5,500 (125 post-reverse split) RSUs, vesting in three approximately equal annual installments beginning on May 31, 2022.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4